^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    FPA157

    i

    Associations

    News
    Trials
    Company:
    Amgen, BMS
    Drug class:
    CCR8 inhibitor
    Related drugs:

    Associations

    News
    Trials